Home Cart 0 Sign in  

[ CAS No. 486460-09-7 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
Chemical Structure| 486460-09-7
Chemical Structure| 486460-09-7
Structure of 486460-09-7 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 486460-09-7 ]

Related Doc. of [ 486460-09-7 ]

Alternatived Products of [ 486460-09-7 ]

Product Details of [ 486460-09-7 ]

CAS No. :486460-09-7 MDL No. :MFCD06659118
Formula : C14H16F3NO4 Boiling Point : -
Linear Structure Formula :- InChI Key :FTWHJNNFVISGNQ-LLVKDONJSA-N
M.W : 319.28 Pubchem ID :7146200
Synonyms :

Calculated chemistry of [ 486460-09-7 ]

Physicochemical Properties

Num. heavy atoms : 22
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.43
Num. rotatable bonds : 7
Num. H-bond acceptors : 7.0
Num. H-bond donors : 2.0
Molar Refractivity : 71.22
TPSA : 75.63 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -6.25 cm/s

Lipophilicity

Log Po/w (iLOGP) : 2.46
Log Po/w (XLOGP3) : 2.82
Log Po/w (WLOGP) : 3.88
Log Po/w (MLOGP) : 3.15
Log Po/w (SILICOS-IT) : 2.99
Consensus Log Po/w : 3.06

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 0.0
Bioavailability Score : 0.56

Water Solubility

Log S (ESOL) : -3.34
Solubility : 0.147 mg/ml ; 0.000461 mol/l
Class : Soluble
Log S (Ali) : -4.07
Solubility : 0.0274 mg/ml ; 0.000086 mol/l
Class : Moderately soluble
Log S (SILICOS-IT) : -3.99
Solubility : 0.0324 mg/ml ; 0.000102 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 1.0 alert
Leadlikeness : 0.0
Synthetic accessibility : 3.15

Safety of [ 486460-09-7 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H302-H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 486460-09-7 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 486460-09-7 ]
  • Downstream synthetic route of [ 486460-09-7 ]

[ 486460-09-7 ] Synthesis Path-Upstream   1~5

  • 1
  • [ 24424-99-5 ]
  • [ 486460-09-7 ]
YieldReaction ConditionsOperation in experiment
100%
Stage #1: for 3 h; Reflux
Stage #2: With sodium carbonate In 1,4-dioxane; water at 0 - 20℃; Alkaline conditions
4.5
(R)-2-(tert-Butoxycarbonylamino)-3-(2,4,5-trifluorophenyl)propanoic acid 5
The heterocyclic intermediate 4 (690 mg, 1.13 mmol) was refluxed in 57percent HI (10 mL) for 3 h.
The reaction mixture was evaporated under vacuum, after which water (23 mL) containing Na2CO3 (1.6 g, 15 mmol) was added (reaction mixture pH should be basic), and cooled to 0 °C. Di-tert-butyl dicarbonate (567 mg, 2.3 equiv) in 1,4-dioxane (14 mL) was added slowly and stirred for 12 h, then slowly warmed up to rt.
Water was added to the reaction mixture and extracted with ether.
The aqueous layer was acidified with aqueous citric acid solution up to pH 2 and extracted with ethyl acetate.
The combined organic layer was washed with brine, dried over anhydrous Na2SO4, filtered, and evaporated under vacuum.
The crude product was purified by column chromatography eluting with 30percent ethyl acetate in hexane and afforded a white powder in about quantitative yield. Mp: 107-110 °C; [α]D25.3 = -1.5 (c 0.12, CH3OH); {lit.
16
[α]D20 = -3.5 (c 1.0, CH3OH)}; 1H NMR (400 MHz, CD3OD) δ 1.37 (s, 9H), 2.87-2.82 (m, 1H), 3.31-3.22 (m, 1H), 4.38-4.34 (m, 1H), 7.23-7.07 (m, 2H); 13C NMR (100 MHz, CD3OD) δ 27.2, 30.4, 30.7, 53.2, 54.5, 79.2, 80.1, 104.6, 104.8, 104.8, 105.1, 118.9, 119.0, 119.1, 121.1, 121.3, 145.1, 145.2, 147.5, 147.6, 150.0, 150.1, 150.2, 155.2, 155.3, 155.5, 156.2, 157.6, 157.7, 173.1; MS (ESI) m/z: 219.9 (M+1H-t-Boc)+. HRMS (ESI) (M+1H-t-Boc)+: calcd for C14H16F3NO4: 220.0585; found: 220.0576.
Reference: [1] Tetrahedron Asymmetry, 2014, vol. 25, # 13-14, p. 1026 - 1030
  • 2
  • [ 486460-08-6 ]
  • [ 486460-09-7 ]
Reference: [1] Journal of Medicinal Chemistry, 2005, vol. 48, # 1, p. 141 - 151
[2] Patent: WO2006/23750, 2006, A2, . Location in patent: Page/Page column 43
  • 3
  • [ 157911-56-3 ]
  • [ 486460-09-7 ]
Reference: [1] Journal of Medicinal Chemistry, 2005, vol. 48, # 1, p. 141 - 151
  • 4
  • [ 486460-07-5 ]
  • [ 486460-09-7 ]
Reference: [1] Journal of Medicinal Chemistry, 2005, vol. 48, # 1, p. 141 - 151
  • 5
  • [ 144284-25-3 ]
  • [ 486460-09-7 ]
Reference: [1] Tetrahedron Asymmetry, 2014, vol. 25, # 13-14, p. 1026 - 1030
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 486460-09-7 ]

Amino Acid Derivatives

Chemical Structure| 167993-00-2

[ 167993-00-2 ]

(S)-2-((tert-Butoxycarbonyl)amino)-3-(2,4-difluorophenyl)propanoic acid

Similarity: 0.97

Chemical Structure| 114873-10-8

[ 114873-10-8 ]

Boc-D-Phe(2-F)-OH

Similarity: 0.96

Chemical Structure| 486460-00-8

[ 486460-00-8 ]

(R)-3-((tert-Butoxycarbonyl)amino)-4-(2,4,5-trifluorophenyl)butanoic acid

Similarity: 0.93

Chemical Structure| 922178-94-7

[ 922178-94-7 ]

(S)-3-((tert-Butoxycarbonyl)amino)-4-(2,4,5-trifluorophenyl)butanoic acid

Similarity: 0.93

Chemical Structure| 205445-53-0

[ 205445-53-0 ]

Boc-D-3,5-Difluorophenylalanine

Similarity: 0.92